We next assessed the ability of pp242 to inhibit p53-dependent responses in ccRCC; CPT-dependent induction of PAI-1 was partially inhibited by pp242 treatment (Figure 7c). The gene discussed is TP53; the disease is nonpapillary renal cell carcinoma.